LiteFold/IEDB huggingface dataset:
Reference: Angelos D Gritzapis; Ioannis F Voutsas; Constantin N Baxevanis. "Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice." Cancer immunology, immunotherapy : CII (2012).

Epitope: HER-2(776-791) p776
Chemical type: Peptide from protein
Sequence: GVGSPYVSRLLGICL
Position: 776-790
Source molecule (GenBank): AAA75493.1
Assay category: TCell
Result: Positive
Host: M 
Cell type: T cell CD4+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: HER-2(776-791) p776
Chemical type: Peptide from protein
Sequence: GVGSPYVSRLLGICL
Position: 776-790
Source molecule (GenBank): AAA75493.1
Assay category: TCell
Result: Positive
Host: M 
Cell type: T cell CD4+
Tissue: spleen
Culture conditions: Direct Ex Vivo
Reference: Kevin C Foy; Megan J Miller; Nicanor Moldovan; William E Carson; Pravin T P Kaumaya. "Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo." Oncoimmunology (2012).

Epitope: MVF-HER-2-266–296(CYC) MVF-HER2
Chemical type: Peptide from protein
Sequence: LHCPALVTYNTDTFESMPNPEGRYTFGASCV
Position: 266-296
Source molecule (GenBank): P04626.1
Assay category: BCell
Result: Positive
Host: F

Epitope: MVF-HER-2-266–296(CYC) MVF-HER2
Chemical type: Peptide from protein
Sequence: LHCPALVTYNTDTFESMPNPEGRYTFGASCV
Position: 266-296
Source molecule (GenBank): P04626.1
Assay category: BCell
Result: Positive
Host: F

Epitope: MVF-HER-2-266–296(CYC) MVF-HER2
Chemical type: Peptide from protein
Sequence: LHCPALVTYNTDTFESMPNPEGRYTFGASCV
Position: 266-296
Source molecule (GenBank): P04626.1
Assay category: BCell
Result: Positive

Epitope: VEGF-P3(CYC)P3
Chemical type: Peptide, no natural source
Sequence: ITMQCGIHQGQHPKIRMICEMSF
Assay category: BCell
Result: Positive
Host: F

Epitope: VEGF-P3(CYC)P3
Chemical type: Peptide, no natural source
Sequence: ITMQCGIHQGQHPKIRMICEMSF
Assay category: BCell
Result: Positive
Host: F

Epitope: RI-VEGF-P4(CYC)P4
Chemical type: Peptide, no natural source
Sequence: FSMECIMRIKPHQGQHIGCQMTI
Assay category: BCell
Result: Positive
Host: F
Reference: Micaela Ippoliti; Marzia Defina; Antonella Gozzini; Claudia Baratè; Lara Aprile; Alice Pietrini; Alessandro Gozzetti; Donatella Raspadori; Francesco Lauria; Monica Bocchia. "Identification of a novel p190-derived breakpoint Peptide suitable for Peptide vaccine therapeutic approach in ph+ acute lymphoblastic leukemia patients." Leukemia research and treatment (2012).

Epitope: BCR:ABL p190-13
Chemical type: Peptide, no natural source
Sequence: PDNGEGAFHGDAEALQRPVASDFEP
Assay category: TCell
Result: Positive
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: BCR:ABL p190-13
Chemical type: Peptide, no natural source
Sequence: PDNGEGAFHGDAEALQRPVASDFEP
Assay category: TCell
Result: Positive
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: BCR:ABL p190-15
Chemical type: Peptide, no natural source
Sequence: DGEGAFHGDAEALQRPVASDFEPQG
Assay category: TCell
Result: Negative
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: BCR:ABL p190-17
Chemical type: Peptide, no natural source
Sequence: EGAFHGDAEALQRPVASDFEPQGLS
Assay category: TCell
Result: Negative
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Ingerid Weum Abrahamsen; Synneva Kjellevoll; Margrethe Greve-Isdahl; Nadia Mensali; Sébastien Wälchli; Shraddha Kumari; Beate Fossum Loland; Torstein Egeland; Arne Kolstad; Johanna Olweus. "T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells." International journal of cancer (2012).

Epitope: CD20 188-196
Chemical type: Peptide from protein
Sequence: SLFLGILSV
Position: 188-196
Source molecule (GenBank): P11836.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CD20 188-196
Chemical type: Peptide from protein
Sequence: SLFLGILSV
Position: 188-196
Source molecule (GenBank): P11836.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: CD20 188-196
Chemical type: Peptide from protein
Sequence: SLFLGILSV
Position: 188-196
Source molecule (GenBank): P11836.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CD20 188-196
Chemical type: Peptide from protein
Sequence: SLFLGILSV
Position: 188-196
Source molecule (GenBank): P11836.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CD20 188-196
Chemical type: Peptide from protein
Sequence: SLFLGILSV
Position: 188-196
Source molecule (GenBank): P11836.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone
Reference: Chie Oshita; Masako Takikawa; Akiko Kume; Haruo Miyata; Tadashi Ashizawa; Akira Iizuka; Yoshio Kiyohara; Shusuke Yoshikawa; Ryuji Tanosaki; Naoya Yamazaki; Akifumi Yamamoto; Kazutoh Takesako; Ken Yamaguchi; Yasuto Akiyama. "Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial." Oncology reports (2012).

Epitope: gp100 209-217
Chemical type: Peptide, no natural source
Sequence: IMDQVPFSV
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: tyrosinase 368-376
Chemical type: Peptide from protein
Sequence: YMDGTMSQV
Assay category: TCell
Result: Negative
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: MAGE-2 157-166
Chemical type: Peptide from protein
Sequence: YLQLVFGIEV
Position: 157-166
Source molecule (GenBank): P43356.1
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: gp100 152-160
Chemical type: Peptide from protein
Sequence: VWKTWGQYW
Position: 152-160
Source molecule (GenBank): P40967.2
Assay category: TCell
Result: Negative
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: tyrosinase 206-214
Chemical type: Peptide from protein
Sequence: AFLPWHRLF
Position: 206-214
Source molecule (GenBank): P14679.3
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: MAGE-1 135-143
Chemical type: Peptide from protein
Sequence: NYKHCFPEI
Position: 135-143
Source molecule (GenBank): AAA03229.1
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: MAGE-2 156-164
Chemical type: Peptide from protein
Sequence: EYLQLVFGI
Position: 156-164
Source molecule (GenBank): P43356.1
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: MAGE-3 195-203
Chemical type: Peptide from protein
Sequence: IMPKAGLLI
Position: 195-203
Source molecule (GenBank): P43357.1
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Erik H J G Aarntzen; Gerty Schreibelt; Kalijn Bol; W Joost Lesterhuis; Alexandra J Croockewit; Johannes H W de Wilt; Michelle M van Rossum; Willeke A M Blokx; Joannes F M Jacobs; Tjitske Duiveman-de Boer; Danita H Schuurhuis; Roel Mus; Kris Thielemans; I Jolanda M de Vries; Carl G Figdor; Cornelis J A Punt; Gosse J Adema. "Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients." Clinical cancer research : an official journal of the American Association for Cancer Research (2012).

Epitope: gp100 154-163
Chemical type: Peptide from protein
Sequence: KTWGQYWQVL
Position: 154-163
Source molecule (GenBank): P40967.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: skin
Culture conditions: Non-antigen specific activation

Epitope: gp100 154-163
Chemical type: Peptide from protein
Sequence: KTWGQYWQVL
Position: 154-163
Source molecule (GenBank): P40967.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: gp100 280-288
Chemical type: Peptide from protein
Sequence: YLEPGPVTA
Position: 280-288
Source molecule (GenBank): P40967.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: skin
Culture conditions: Non-antigen specific activation

Epitope: gp100 280-288
Chemical type: Peptide from protein
Sequence: YLEPGPVTA
Position: 280-288
Source molecule (GenBank): P40967.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: gp100 44-59
Chemical type: Peptide from protein
Sequence: WNRQLYPEWTEAQRLD
Position: 44-59
Source molecule (GenBank): P40967.2
Assay category: TCell
Result: Positive
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: tyrosinase 448-462
Chemical type: Peptide from protein
Sequence: DYSYLQDSDPDSFQD
Position: 448-462
Source molecule (GenBank): P14679.3
Assay category: TCell
Result: Positive
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Jürgen C Becker; Mads H Andersen; Valeska Hofmeister-Müller; Marion Wobser; Lidia Frey; Christiane Sandig; Steffen Walter; Harpreet Singh-Jasuja; Eckhart Kämpgen; Andreas Opitz; Marc Zapatka; Eva-B Bröcker; Per Thor Straten; David Schrama; Selma Ugurel. "Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma." Cancer immunology, immunotherapy : CII (2012).

Epitope: Survivin A2 peptide
Chemical type: Peptide, no natural source
Sequence: LMLGEFLKL
Assay category: TCell
Result: Positive

Epitope: Survivin A2 peptide
Chemical type: Peptide, no natural source
Sequence: LMLGEFLKL
Assay category: TCell
Result: Positive

Epitope: Survivin A2 peptide
Chemical type: Peptide, no natural source
Sequence: LMLGEFLKL
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: Survivin A2 peptide
Chemical type: Peptide, no natural source
Sequence: LMLGEFLKL
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Survivin A2 peptide
Chemical type: Peptide, no natural source
Sequence: LMLGEFLKL
Assay category: TCell
Result: Negative
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Survivin A2 peptide
Chemical type: Peptide, no natural source
Sequence: LMLGEFLKL
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: Survivin A2 peptide
Chemical type: Peptide, no natural source
Sequence: LMLGEFLKL
Assay category: TCell
Result: Negative
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: survivin wt
Chemical type: Peptide from protein
Sequence: LTLGEFLKL
Position: 119-127
Source molecule (GenBank): H3BLT4.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: survivin wt
Chemical type: Peptide from protein
Sequence: LTLGEFLKL
Position: 119-127
Source molecule (GenBank): H3BLT4.1
Assay category: TCell
Result: Negative
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Satoshi Kawaguchi; Tomohide Tsukahara; Kazunori Ida; Shigeharu Kimura; Masaki Murase; Masanobu Kano; Makoto Emori; Satoshi Nagoya; Mitsunori Kaya; Toshihiko Torigoe; Emiri Ueda; Akari Takahashi; Takeshi Ishii; Shin-ichiro Tatezaki; Junya Toguchida; Hiroyuki Tsuchiya; Toshihisa Osanai; Takashi Sugita; Hideshi Sugiura; Makoto Ieguchi; Koichiro Ihara; Ken-ichiro Hamada; Hiroshi Kakizaki; Takeshi Morii; Taketoshi Yasuda; Taisuke Tanizawa; Akira Ogose; Hiroo Yabe; Toshihiko Yamashita; Noriyuki Sato; Takuro Wada. "SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group." Cancer science (2012).

Epitope: Peptide B
Chemical type: Peptide from protein
Sequence: GYDQIMPKK
Position: 376-384
Source molecule (GenBank): A4PIW0.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Peptide B
Chemical type: Peptide from protein
Sequence: GYDQIMPKK
Position: 376-384
Source molecule (GenBank): A4PIW0.1
Assay category: TCell
Result: Negative

Epitope: Peptide B
Chemical type: Peptide from protein
Sequence: GYDQIMPKK
Position: 376-384
Source molecule (GenBank): A4PIW0.1
Assay category: TCell
Result: Positive

Epitope: Peptide B
Chemical type: Peptide from protein
Sequence: GYDQIMPKK
Position: 376-384
Source molecule (GenBank): A4PIW0.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Peptide K9I
Chemical type: Peptide, no natural source
Sequence: GYDQIMPKI
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Peptide K9I
Chemical type: Peptide, no natural source
Sequence: GYDQIMPKI
Assay category: TCell
Result: Negative

Epitope: Peptide K9I
Chemical type: Peptide, no natural source
Sequence: GYDQIMPKI
Assay category: TCell
Result: Positive

Epitope: Peptide K9I
Chemical type: Peptide, no natural source
Sequence: GYDQIMPKI
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo
Reference: Toru Masuzawa; Yoshiyuki Fujiwara; Kaoru Okada; Ayumu Nakamura; Shuji Takiguchi; Kiyokazu Nakajima; Hiroshi Miyata; Makoto Yamasaki; Yukinori Kurokawa; Ryuji Osawa; Kazuyoshi Takeda; Koji Yoshida; Takuya Tsunoda; Yusuke Nakamura; Masaki Mori; Yuichiro Doki. "Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer." International journal of oncology (2012).

Epitope: VEGFR1-1084
Chemical type: Peptide from protein
Sequence: SYGVLLWEIF
Position: 1084-1093
Source molecule (GenBank): P17948.2
Assay category: TCell
Result: Positive
Cell type: T cell CD4-
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: VEGFR2-169
Chemical type: Peptide from protein
Sequence: RFVPDGNRI
Position: 169-177
Source molecule (GenBank): P35968.2
Assay category: TCell
Result: Positive
Cell type: T cell CD4-
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Katalin Uray; Ferenc Hudecz. "Effect of core epitope modification on the antibody recognition of a MUC2 mucin peptide." Molecular diversity (2012).

Epitope: mAb 996 epitope
Chemical type: Peptide from protein
Sequence: PTGTQ
Position: 1933-1937
Source molecule (GenBank): NP_002448.5
Assay category: BCell
Result: Positive

Epitope: mAb 996 epitope
Chemical type: Peptide from protein
Sequence: PTGTQ
Position: 1933-1937
Source molecule (GenBank): NP_002448.5
Assay category: BCell
Result: Positive

Epitope: mAb 996 epitope
Chemical type: Peptide from protein
Sequence: PTGTQ
Position: 1933-1937
Source molecule (GenBank): NP_002448.5
Assay category: BCell
Result: Positive
Quantitative measurement: 9500.0
Reference: Suguru Yonezawa; Shinichi Kitajima; Michiyo Higashi; Masahiko Osako; Michiko Horinouchi; Seiya Yokoyama; Sho Kitamoto; Norishige Yamada; Yukihiro Tamura; Takeshi Shimizu; Mineo Tabata; Masamichi Goto. "A novel anti-MUC1 antibody against the MUC1 cytoplasmic tail domain: use in sensitive identification of poorly differentiated cells in adenocarcinoma of the stomach." Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2012).

Epitope: MUC1 common
Chemical type: Peptide from protein
Sequence: RYVPPSSTDRSPYEKVSAG
Position: 1217-1235
Source molecule (GenBank): P15941.2
Assay category: BCell
Result: Positive-High

Epitope: MUC1*1110-ecd_P epitope
Chemical type: Peptide from protein
Sequence: GTINVHDVETQFNQYKTEAASPYNLTISDVSVSDVPFPFSAQSGA
Assay category: BCell
Result: Positive
Reference: Bianca Altvater; Sibylle Pscherer; Silke Landmeier; Sareetha Kailayangiri; Barbara Savoldo; Heribert Juergens; Claudia Rossig. "Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens." Cancer immunology, immunotherapy : CII (2012).

Epitope: FLY
Chemical type: Peptide from protein
Sequence: FLYTLLREV
Position: 86-94
Source molecule (GenBank): Q9UHE8.1
Assay category: TCell
Result: Negative
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: GLL
Chemical type: Peptide from protein
Sequence: GLLSFFFAV
Position: 165-173
Source molecule (GenBank): Q9UHE8.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: LLL
Chemical type: Peptide from protein
Sequence: LLLGTIHAL
Position: 262-270
Source molecule (GenBank): Q9UHE8.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: MIA
Chemical type: Peptide from protein
Sequence: MIAVFLPIV
Position: 292-300
Source molecule (GenBank): Q9UHE8.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Seth M Pollack; Yonqing Li; Megan J Blaisdell; Erik A Farrar; Jeffrey Chou; Benjamin L Hoch; Elizabeth T Loggers; Eve Rodler; Janet F Eary; Ernest U Conrad; Robin L Jones; Cassian Yee. "NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine." PloS one (2012).

Epitope: NY-ESO-1 (157-165)
Chemical type: Peptide from protein
Sequence: SLLMWITQC
Position: 157-165
Source molecule (GenBank): CAA05908.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: NY-ESO-1 (157-165)
Chemical type: Peptide from protein
Sequence: SLLMWITQC
Position: 157-165
Source molecule (GenBank): CAA05908.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: PRAME (300-309)
Chemical type: Peptide from protein
Sequence: ALYVDSLFFL
Position: 300-309
Source molecule (GenBank): P78395.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: PRAME (300-309)
Chemical type: Peptide from protein
Sequence: ALYVDSLFFL
Position: 300-309
Source molecule (GenBank): P78395.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Yi Gang; Xiaoyin Zhang; Yuanlong He; Jianyong Zheng; Kaichun Wu; Jie Ding; Daiming Fan. "Efficient induction of specific cytotoxic T lymphocytes against gastric adenocarcinoma by a survivin peptide." Biochemistry and cell biology = Biochimie et biologie cellulaire (2012).

Epitope: Survivin
Chemical type: Peptide, no natural source
Sequence: LMLGEFLKL
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: Survivin
Chemical type: Peptide, no natural source
Sequence: LMLGEFLKL
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: Survivin
Chemical type: Peptide, no natural source
Sequence: LMLGEFLKL
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: Survivin
Chemical type: Peptide, no natural source
Sequence: LMLGEFLKL
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: Survivin
Chemical type: Peptide, no natural source
Sequence: LMLGEFLKL
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Huiwen Liu; Lu Huang; Jiaquan Luo; Wenzhao Chen; Zhanmin Zhang; Xiang Liao; Min Dai; Yong Shu; Kai Cao. "Prediction and identification of B cell epitopes derived from EWS/FLI-l fusion protein of Ewing's sarcoma." Medical oncology (Northwood, London, England) (2012).

Epitope: P3
Chemical type: Peptide, no natural source
Sequence: QQNPSYDSVRRGAW
Assay category: BCell
Result: Negative
Host:  15-20 weeks

Epitope: P3
Chemical type: Peptide, no natural source
Sequence: QQNPSYDSVRRGAW
Assay category: BCell
Result: Positive
Host:  15-20 weeks

Epitope: P3
Chemical type: Peptide, no natural source
Sequence: QQNPSYDSVRRGAW
Assay category: BCell
Result: Positive
Host:  15-20 weeks

Epitope: P1
Chemical type: Peptide from protein
Sequence: PQDGNKPTETSQPQ
Position: 139-152
Source molecule (GenBank): Q01844.1
Assay category: BCell
Result: Positive
Host:  15-20 weeks

Epitope: P1
Chemical type: Peptide from protein
Sequence: PQDGNKPTETSQPQ
Position: 139-152
Source molecule (GenBank): Q01844.1
Assay category: BCell
Result: Positive
Host:  15-20 weeks

Epitope: P1
Chemical type: Peptide from protein
Sequence: PQDGNKPTETSQPQ
Position: 139-152
Source molecule (GenBank): Q01844.1
Assay category: BCell
Result: Positive
Host:  15-20 weeks

Epitope: P2
Chemical type: Peptide from protein
Sequence: DPDEVARRWGQRKS
Position: 247-260
Source molecule (GenBank): AAA58480.1
Assay category: BCell
Result: Positive
Host:  15-20 weeks

Epitope: P2
Chemical type: Peptide from protein
Sequence: DPDEVARRWGQRKS
Position: 247-260
Source molecule (GenBank): AAA58480.1
Assay category: BCell
Result: Positive
Host:  15-20 weeks

Epitope: P2
Chemical type: Peptide from protein
Sequence: DPDEVARRWGQRKS
Position: 247-260
Source molecule (GenBank): AAA58480.1
Assay category: BCell
Result: Positive
Host:  15-20 weeks
Reference: Shamaila Munir; Thomas Mørch Frøsig; Morten Hansen; Inge Marie Svane; Mads Hald Andersen. "Characterization of T-cell responses against IκBα in cancer patients." Oncoimmunology (2012).

Epitope: IκB10
Chemical type: Peptide from protein
Sequence: HLASIHGYL
Position: 188-196
Source molecule (GenBank): G3V3I4.1
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: IκB10
Chemical type: Peptide from protein
Sequence: HLASIHGYL
Position: 188-196
Source molecule (GenBank): G3V3I4.1
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: IκB10
Chemical type: Peptide from protein
Sequence: HLASIHGYL
Position: 188-196
Source molecule (GenBank): G3V3I4.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: IκB10
Chemical type: Peptide from protein
Sequence: HLASIHGYL
Position: 188-196
Source molecule (GenBank): G3V3I4.1
Assay category: TCell
Result: Positive
Cell type: T cell
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: IκB10
Chemical type: Peptide from protein
Sequence: HLASIHGYL
Position: 188-196
Source molecule (GenBank): G3V3I4.1
Assay category: TCell
Result: Positive
Cell type: T cell
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: IκB10
Chemical type: Peptide from protein
Sequence: HLASIHGYL
Position: 188-196
Source molecule (GenBank): G3V3I4.1
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: IκB10
Chemical type: Peptide from protein
Sequence: HLASIHGYL
Position: 188-196
Source molecule (GenBank): G3V3I4.1
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: IκB10
Chemical type: Peptide from protein
Sequence: HLASIHGYL
Position: 188-196
Source molecule (GenBank): G3V3I4.1
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: IκB10
Chemical type: Peptide from protein
Sequence: HLASIHGYL
Position: 188-196
Source molecule (GenBank): G3V3I4.1
Assay category: MhcBinding
Result: Positive